Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Towards Elimination of Cervical Cancer – Human Papillomavirus (Hpv) Vaccination and Cervical Cancer Screening in Asian National Cancer Centers Alliance (Ancca) Member Countries Publisher



Ong SK1 ; Abe SK2 ; Thilagaratnam S3 ; Haruyama R4 ; Pathak R5 ; Jayasekara H6 ; Togawa K2 ; Bhandari AKC2 ; Shankar A7 ; Nessa A8 ; Jugder U9 ; Agustina J10 ; Biglari M11 ; Yusuf A12 Show All Authors
Authors
  1. Ong SK1
  2. Abe SK2
  3. Thilagaratnam S3
  4. Haruyama R4
  5. Pathak R5
  6. Jayasekara H6
  7. Togawa K2
  8. Bhandari AKC2
  9. Shankar A7
  10. Nessa A8
  11. Jugder U9
  12. Agustina J10
  13. Biglari M11
  14. Yusuf A12
  15. Tshomo U13
  16. Fernando E14
  17. Cairo C15
  18. Kaung KK16
  19. Rath B17
  20. Vongdala C18
  21. Pradhananga KK19
  22. Kim J20
  23. Chung YK20
  24. Thanh Huong TT21
  25. Sangrajran S22
  26. Zhang Y23
  27. Basu P24
  28. Woo YL25
  29. Sukumaran B26
  30. Hwang WYK27
Show Affiliations
Authors Affiliations
  1. 1. PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam, Brunei Darussalam
  2. 2. National Cancer Center Institute for Cancer Control, Tokyo, Japan
  3. 3. Health Promotion Board, Singapore
  4. 4. Bureau of International Health Cooperation, National Center for Global Health and Medicine, Japan
  5. 5. Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, India
  6. 6. Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia
  7. 7. Department of Radiation Oncology, Dr B R Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Delhi, India
  8. 8. Department of Gynaecological Oncology, Bangabandhu Sheikh Mujib Medical University, Bangladesh
  9. 9. Cancer Registry-surveillance and Early Detection Division, National Cancer Center of Mongolia, Ulaanbaatar, Mongolia
  10. 10. National Cancer Center Indonesia, Dharmais Cancer Hospital, Jakarta, Indonesia
  11. 11. Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran
  12. 12. Shaukat Khanum Memorial Cancer Hospital and Research Centres, Lahore and Peshawar, Pakistan
  13. 13. Jigme Dorji Wangchuck National Referral Hospital, Bhutan
  14. 14. National Cancer Control Programme, Ministry of Health, Sri Lanka
  15. 15. Department of Health, Disease Prevention and Control Bureau, Manila, Philippines
  16. 16. Department of Public Health, Ministry of Health, Naypyidaw, Myanmar
  17. 17. Calmette Hospital, Phnom Penh, Cambodia
  18. 18. Cancer Center, Mittaphab Hospital, Vientiane, Laos
  19. 19. Kathmandu Cancer Center Hospital, Tathali, Bhaktapur, Nepal
  20. 20. National Cancer Center Korea, Goyang, South Korea
  21. 21. Vietnam National Cancer Institute & Hanoi Medical University, Hanoi, Viet Nam
  22. 22. National Cancer Institute, Bangkok, Thailand
  23. 23. National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  24. 24. International Agency for Research on Cancer (IARC/WHO), Lyon, France
  25. 25. University of Malaya & ROSE Foundation, Kuala Lumpur, Malaysia
  26. 26. The Brunei Cancer Center, PJSC, Brunei Darussalam
  27. 27. National Cancer Centre & Duke-NUS Medical School, Singapore

Source: The Lancet Regional Health - Western Pacific Published:2023


Abstract

About 95% of cervical cancers worldwide are caused by human papillomavirus (HPV). Cervical cancer is preventable and curable if it is detected and treated early. We reviewed the latest national cervical cancer indicators, and barriers to HPV vaccination and cervical cancer screening in 21 Asian National Cancer Centers Alliance (ANCCA) member countries. Half (n = 11, 52%) of the countries have introduced HPV vaccination for girls as part of their national vaccination programme, three countries reported coverage of over 90%. Most ANCCA member countries have cervical cancer screening programmes, only five countries reported screening uptake of over 50%. The barriers to HPV vaccination coverage and cervical cancer screening participation have been identified. Ensuring health service accessibility and affordability for women, addressing sociocultural barriers, and strengthening the healthcare system and continuum of care are essential to increase HPV vaccination and cervical cancer screening coverage. © 2023